| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children and adolescents: a systematic review R Castagnoli, M Votto, A Licari, I Brambilla, R Bruno, S Perlini, F Rovida, ... JAMA pediatrics 174 (9), 882-889, 2020 | 1341 | 2020 |
| Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types C Rapezzi, G Merlini, CC Quarta, L Riva, S Longhi, O Leone, F Salvi, ... Circulation 120 (13), 1203-1212, 2009 | 845 | 2009 |
| Proposal for international standardization of the use of lung ultrasound for patients with COVID‐19: a simple, quantitative, reproducible method G Soldati, A Smargiassi, R Inchingolo, D Buonsenso, T Perrone, ... Journal of Ultrasound in Medicine 39 (7), 1413-1419, 2020 | 681 | 2020 |
| Serum N-terminal pro–brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis G Palladini, C Campana, C Klersy, A Balduini, G Vadacca, V Perfetti, ... Circulation 107 (19), 2440-2445, 2003 | 596 | 2003 |
| Is there a role for lung ultrasound during the COVID‐19 pandemic? G Soldati, A Smargiassi, R Inchingolo, D Buonsenso, T Perrone, ... Journal of Ultrasound in Medicine 39 (7), 1459, 2020 | 565 | 2020 |
| Circulating amyloidogenic free light chains and serum N-terminal natriuretic peptide type B decrease simultaneously in association with improvement of survival in AL G Palladini, F Lavatelli, P Russo, S Perlini, V Perfetti, T Bosoni, L Obici, ... Blood 107 (10), 3854-3858, 2006 | 358 | 2006 |
| Evidence for an intrinsic mechanism regulating heart rate variability in the transplanted and the intact heart during submaximal dynamic exercise? L Bernardi, F Salvucci, R Suardi, PL Soldá, A Calciati, S Perlini, ... Cardiovascular research 24 (12), 969-981, 1990 | 343 | 1990 |
| Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: an Italian perspective C Rapezzi, CC Quarta, L Obici, F Perfetto, S Longhi, F Salvi, E Biagini, ... European heart journal 34 (7), 520-528, 2013 | 337 | 2013 |
| Performance of VivaDiag COVID‐19 IgM/IgG Rapid Test is inadequate for diagnosis of COVID‐19 in acute patients referring to emergency room department I Cassaniti, F Novazzi, F Giardina, F Salinaro, M Sachs, S Perlini, R Bruno, ... Journal of medical virology 92 (10), 1724, 2020 | 264 | 2020 |
| The combination of thalidomide and intermediate-dose dexamethasone is an effective but toxic treatment for patients with primary amyloidosis (AL) G Palladini, V Perfetti, S Perlini, L Obici, F Lavatelli, R Caccialanza, ... Blood 105 (7), 2949-2951, 2005 | 258 | 2005 |
| Doxycycline plus tauroursodeoxycholic acid for transthyretin amyloidosis: a phase II study L Obici, A Cortese, A Lozza, J Lucchetti, M Gobbi, G Palladini, S Perlini, ... Amyloid 19 (sup1), 34-36, 2012 | 246 | 2012 |
| The combination of high-sensitivity cardiac troponin T (hs-cTnT) at presentation and changes in N-terminal natriuretic peptide type B (NT-proBNP) after chemotherapy best … G Palladini, A Barassi, C Klersy, R Pacciolla, P Milani, G Sarais, S Perlini, ... Blood, The Journal of the American Society of Hematology 116 (18), 3426-3430, 2010 | 238 | 2010 |
| Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian … A Di Castelnuovo, M Bonaccio, S Costanzo, A Gialluisi, A Antinori, ... Nutrition, Metabolism and Cardiovascular Diseases 30 (11), 1899-1913, 2020 | 191 | 2020 |
| Clinical characteristics of coronavirus disease (COVID-19) early findings from a teaching hospital in Pavia, North Italy, 21 to 28 February 2020 M Colaneri, P Sacchi, V Zuccaro, S Biscarini, M Sachs, S Roda, TC Pieri, ... Eurosurveillance 25 (16), 2000460, 2020 | 190 | 2020 |
| Noncontrast magnetic resonance for the diagnosis of cardiac amyloidosis A Baggiano, M Boldrini, A Martinez-Naharro, T Kotecha, A Petrie, T Rezk, ... Cardiovascular Imaging 13 (1_Part_1), 69-80, 2020 | 175 | 2020 |
| Prevention of recurrent lone atrial fibrillation by the angiotensin-II converting enzyme inhibitor ramipril in normotensive patients F Belluzzi, L Sernesi, P Preti, F Salinaro, ML Fonte, S Perlini Journal of the American College of Cardiology 53 (1), 24-29, 2009 | 175 | 2009 |
| Oral melphalan and dexamethasone grants extended survival with minimal toxicity in AL amyloidosis: long-term results of a risk-adapted approach G Palladini, P Milani, A Foli, L Obici, F Lavatelli, M Nuvolone, ... haematologica 99 (4), 743, 2014 | 173 | 2014 |
| Multiparametric echocardiography scores for the diagnosis of cardiac amyloidosis M Boldrini, F Cappelli, L Chacko, MA Restrepo-Cordoba, A Lopez-Sainz, ... Cardiovascular Imaging 13 (4), 909-920, 2020 | 168 | 2020 |
| Effects of tafamidis on transthyretin stabilization and clinical outcomes in patients with non-Val30Met transthyretin amyloidosis G Merlini, V Planté-Bordeneuve, DP Judge, H Schmidt, L Obici, S Perlini, ... Journal of cardiovascular translational research 6, 1011-1020, 2013 | 168 | 2013 |
| Increased prevalence of metabolic syndrome in uncontrolled hypertension across Europe: the Global Cardiometabolic Risk Profile in Patients with hypertension disease survey SE Kjeldsen, L Naditch-Brule, S Perlini, W Zidek, C Farsang Journal of hypertension 26 (10), 2064-2070, 2008 | 166 | 2008 |
